The blue cluster focuses on metabolic disorders, cardiovascular and kidney diseases, lipid metabolism, insulin resistance, mitochondrial biogenesis, regulation of adipose tissue and skeletal muscle, diet and nutrition, as well as the molecular mechanisms and pathological processes associated with Ampk, SIRT1, and PPAR-gamma pathways. This evidence concerns the gene INS and metabolic disease.